For many women living with endometriosis, getting a diagnosis can take years. In the UK, the average diagnosis time is more than nine years, leaving many to cope with chronic pain, repeated GP visits and significant impacts on their daily lives.
There is now encouraging news from the National Institute for Health and Care Excellence (NICE).
Two New Non-Invasive Tests Recommended
NICE has published draft guidance recommending the early NHS use of two innovative diagnostic technologies, Endotest and EndoSure, while further evidence is gathered over the next three years.
Unlike a diagnostic laparoscopy, which requires surgery, these tests are non-invasive:
These tests are designed to support healthcare professionals when endometriosis is still suspected despite normal examinations or inconclusive imaging. They are not standalone diagnostic tests but could help identify women who need earlier referral and treatment.
Why This Matters
Research shows that many people with endometriosis visit their GP multiple times before receiving a diagnosis, with some attending emergency departments because of severe symptoms. Delays can lead to worsening pain, disease progression and unnecessary suffering.
Earlier diagnosis has the potential to:
Continued Progress in Endometriosis Care
These diagnostic developments are part of a wider programme of improvements from NICE. Recent updates include:
Looking Ahead
Although these technologies are still being evaluated, they represent an important step towards reducing the long delays that so many people with endometriosis experience. Earlier recognition and diagnosis could make a significant difference to patients’ lives by helping them access the care and treatment they need sooner.
As evidence continues to grow, these developments offer real hope for improving the diagnosis and management of endometriosis across the NHS.
To read the article in full or follow stories of sufferers see the links below:
New technologies could help cut years-long wait for endometriosis diagnosis
Endometriosis groups ‘crying out’ for cut in diagnosis time
‘I lost years waiting for endometriosis diagnosis’
Clopidogrel is an antiplatelet medication used to prevent blood clots. It requires the CYP2C19 liver enzyme to work. Variations in your DNA can reduce this enzyme’s function, making the drug less effective and increasing the risk of serious cardiovascular events like heart attacks or strokes.
Hereditary Cancer Awareness Week is a valuable reminder that family history matters. NHS genetic testing is available for many people at higher risk, but not everyone will meet the criteria for testing on the NHS. If this has happened to you, it does not mean your concerns are not valid. It simply means you may need another route to get the information you are looking for.
Since the UK National Screening Committee (UK NSC) recommended targeted prostate screening for men aged 45 to 61 who carry a BRCA2 gene change and have a family history of specific cancers in May 2026, there has been a rapid increase in the number of Hereditary Cancer tests requested. Learn why…
The first in a new series of blogs explaining in more detail how the Gender Reveal test works begins with the most common question “what if the result is inconclusive?” What does that mean. Learn more about what causes it.